BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7196888)

  • 1. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
    Morrison NE; Collins FM
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones.
    Collins FM; Klayman DL; Morrison NE
    J Gen Microbiol; 1982 Jun; 128(6):1349-56. PubMed ID: 6811692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 2-acetylpyridine and 2-acetylquinoline thiosemicarbazones tested in vitro in combination with other antituberculous drugs.
    Collins FM; Klayman DL; Morrison NE
    Am Rev Respir Dis; 1982 Jan; 125(1):58-60. PubMed ID: 6175259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental study of the antileprosy activity of a series of thioamides in the mouse.
    Shepard CC; Jenner PJ; Ellard GA; Lancaster RD
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):587-94. PubMed ID: 3910748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
    Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D; Manjashetty TH
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1152-4. PubMed ID: 19131245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648.
    Tomioka H; Saito H
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):255-8. PubMed ID: 8371034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new antitubercular oxazolyl thiosemicarbazones.
    Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK
    J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro.
    Gangadharam PR; Candler ER
    Am Rev Respir Dis; 1977 Apr; 115(4):705-8. PubMed ID: 557943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent studies of antileprosy drugs.
    Shepard CC; Van Landingham RM; Walker LL
    Lepr Rev; 1983 Jun; Spec No():23-30. PubMed ID: 6350771
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
    Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
    J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.
    Güzel O; Karali N; Salman A
    Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
    Seidel V; Taylor PW
    Int J Antimicrob Agents; 2004 Jun; 23(6):613-9. PubMed ID: 15194133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antimycobacterial activity of nitroxanthones. 2nd communication: antimycobacterial activity.
    Ibrom WG; Schaper KJ; Frahm AW
    Arzneimittelforschung; 1997 Jun; 47(6):767-73. PubMed ID: 9239457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of novel metal complexes of 2-acetylpyridine thiosemicarbazones.
    Offiong OE; Martelli S
    Farmaco; 1995 Sep; 50(9):625-32. PubMed ID: 7495474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antibacterial and antifungal activity of metal (II) complexes of 2-acetylpyridine thiosemicarbazones.
    Offiong OE; Martelli S
    Farmaco; 1993 Jun; 48(6):777-93. PubMed ID: 8373503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Acetylpyridine thiosemicarbazones and Mycobacterium leprae.
    Shepard CC; Klayman DL; Scovill JP; Morrison NE
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):7-9. PubMed ID: 6368429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.